{"database": "lobbying", "table": "lobbying_activities", "rows": [[2504264, "6898294b-9de9-44a6-8fbd-44ffc418c4ce", "Q3", "TODD STRATEGY GROUP", 401103321, "BIODESIX, INC.", 2020, "third_quarter", "MMM", "Implementation of changes to Medicare payments for clinical laboratory tests.\nMedicare treatment of outpatient reimbursement for laboratory tests.\nFDA regulation of laboratory developed tests (LDTs).", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-10-06T11:50:16.917000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2504264"], "units": {}, "query_ms": 1.5202909708023071, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}